Literature DB >> 6379173

Production in vitro of mouse early pregnancy factor and purification to homogeneity.

A C Cavanagh.   

Abstract

Early pregnancy factor (EPF) has been produced in vitro by culture of oestrous mouse oviducts and ovaries in RPMI, with the addition of prolactin and mouse embryo culture medium. The pooled harvested medium was then subjected to immunoabsorption, electrofocusing and gel filtration. A fraction was isolated with pI 6.83 and molecular weight 21 000 which was responsible for 90% of the recovered biological activity. It appeared to be homogeneous when analysed by high-performance gel-permeation chromatography. SDS treatment showed that the molecule could be split into 3 peptides of molecular weights 10 500, 7200 and 3400, the first having activity equivalent to the EPF component EPF-A from the oviduct, while the last two combined to give activity corresponding with the ovarian component EPF-B.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6379173     DOI: 10.1530/jrf.0.0710581

Source DB:  PubMed          Journal:  J Reprod Fertil        ISSN: 0022-4251


  5 in total

1.  Induction of early pregnancy factor from mouse metoestrous ovaries and oviducts in vitro by steroid hormones.

Authors:  G E Lash; M Legge
Journal:  J Assist Reprod Genet       Date:  2000-03       Impact factor: 3.412

2.  Synthesis of early pregnancy factor using red deer (Cervus elaphus) as a delayed implantation model.

Authors:  G E Lash; M Legge; M Fisher
Journal:  J Assist Reprod Genet       Date:  1997-01       Impact factor: 3.412

3.  Identification of two suppressor factors induced by early pregnancy factor.

Authors:  B E Rolfe; A C Cavanagh; K A Quinn; H Morton
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

4.  Effect of monoclonal antibodies to early pregnancy factor (EPF) on the in vivo growth of transplantable murine tumours.

Authors:  K A Quinn; H Morton
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

5.  Monoclonal antibodies to early pregnancy factor perturb tumour cell growth.

Authors:  K A Quinn; S Athanasas-Platsis; T Y Wong; B E Rolfe; A C Cavanagh; H Morton
Journal:  Clin Exp Immunol       Date:  1990-04       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.